1)Bennett JE, et al(eds):Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 8th ed., pp 748-752.e2., Elsevier, Amsterdam, 2015
2)Del Rio-Pertuz G, et al:Usefulness of sputum gram stain for etiologic diagnosis in community-acquired pneumonia;A systematic review and meta-analysis. BMC Infect Dis 19:403, 2019
3)NICE:COVID-19 rapid guideline:managing COVID-19, NICE guideline[NG191], 2021 https://www.nice.org.uk/guidance/ng191(2022年3月閲覧)
4)Farrell JM, et al:Causes and consequences of COVID-19-associated bacterial infections. Front Microbiol 12:682571, 2021
5)Rawson TM,et al:Bacterial and fungal coinfection in individuals with coronavirus;A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis 71:2459-2468, 2020
6)Baghdadi JD,et al:Antibiotic use and bacterial infection among inpatients in the first wave of COVID-19;A retrospective cohort study of 64,691 patients. Antimicrob Agents Chemother 65:e0134121, 2021
7)Chen N, et al:Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China;A descriptive study. Lancet 395:507-513, 2020
8)Chen S, et al:Rotavirus infection and cytopathogenesis in human biliary organoids potentially recapitulate biliary atresia development. mBio 11:e01968-20, 2020
9)He S,et al:Clinical characteristics of COVID-19 patients with clinically diagnosed bacterial co-infection;A multi-center study. PLoS One 16:e0249668, 2021
10)Koehler P, et al:Defining and managing COVID-19-associated pulmonary aspergillosis;The 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis 21:e149-e162, 2021
11)Takazono T, et al:COVID-19 associated pulmonary aspergillosis;A nationwide survey by the Japanese Respiratory Society. ERJ Open Res 7:00402-2021, 2021